Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001879785-21-000041)

Filing Details

Accession Number:: 0001879785-21-000041
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-14 18:19:48
Reporting Period:: 2021-12-10

Accepted Time:: 2021-12-14 18:19:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534120	Avalo Therapeutics Inc.	AVTX	Pharmaceutical Preparations (2834)	450705648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1779160	Jeffrey H Wilkins	C/O Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD 20850	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-10	6,371	$1.57	33,373	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.